EMA recommends approval of Bimervax as a COVID-19 booster vaccine

30 marzo 2023 – EMA’s human medicines committee (CHMP) has recommended authorising the COVID-19 vaccine Bimervax (previously COVID-19 Vaccine HIPRA) as a booster in people aged 16 years and above who have been vaccinated with an mRNA COVID-19 vaccine.

For more information, see here.